<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Guidance for Industry on Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Guidance for Industry on Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling; Availability</h1>
    <p class="timestamp">Published: 2013-01-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling." This guidance is intended to assist the pharmaceutical industry and other investigators engaged in new drug development in evaluating how variations in the human genome, specifically DNA sequence variants, could affect a drug's pharmacokinetics (PK), pharmacodynamics (PD), effi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-01638</p>
    <p><strong>Publication Date:</strong> 2013-01-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/01/28/2013-01638/guidance-for-industry-on-clinical-pharmacogenomics-premarket-evaluation-in-early-phase-clinical">https://www.federalregister.gov/documents/2013/01/28/2013-01638/guidance-for-industry-on-clinical-pharmacogenomics-premarket-evaluation-in-early-phase-clinical</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-01638</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
